We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Urges Sponsors to Minimize Design Changes in Generic Drug Delivery Products
FDA Urges Sponsors to Minimize Design Changes in Generic Drug Delivery Products
Manufacturers seeking approval for generic versions of drug-device combination products, such as prefilled syringes and auto-injectors, should strongly consider minimizing the differences between the generic’s user interface and that of the reference product, FDA advised in new draft guidance.